Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 12, Issue 5, Pages 910
Publisher
MDPI AG
Online
2023-05-16
DOI
10.3390/antibiotics12050910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
- (2022) Sadia H Sarzynski et al. Open Forum Infectious Diseases
- Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
- (2022) Ravina Kullar et al. Open Forum Infectious Diseases
- Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center “Proof-of-Concept” Study
- (2022) Davide Fiore Bavaro et al. Open Forum Infectious Diseases
- Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion
- (2022) Nicola Coppola et al. Antibiotics-Basel
- Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate
- (2021) Mohammed Alsuhaibani et al. Antimicrobial Resistance and Infection Control
- Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of art and research agenda
- (2021) Maddalena Giannella et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
- (2021) Tanya Babich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in Italy
- (2021) Stefano Stracquadanio et al. Journal of Global Antimicrobial Resistance
- Advances in the Microbiology of Stenotrophomonas maltophilia
- (2021) Joanna S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy
- (2021) Shauna Jacobson Junco et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision
- (2021) Andrew J Fratoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Stenotrophomonas maltophilia Susceptibility Testing Challenges and Strategies
- (2021) Daniel D. Rhoads JOURNAL OF CLINICAL MICROBIOLOGY
- Stenotrophomonas maltophilia bacteraemia: 61 cases in a tertiary hospital in Denmark
- (2021) Magnus G. Ahlström et al. Infectious Diseases
- The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases
- (2021) Carola Mauri et al. Antibiotics-Basel
- Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
- (2021) Lei Zha et al. Infectious Diseases and Therapy
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Effect of antibiotic therapy on the prognosis of ventilator-associated pneumonia caused by Stenotrophomonas maltophilia
- (2021) Bérénice Puech et al. Annals of Intensive Care
- Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
- (2020) Marco Fiore et al. Antibiotics-Basel
- Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug resistant Stenotrophomonas maltophilia
- (2020) M Biagi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study
- (2020) Meng Xiao et al. BMC MICROBIOLOGY
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
- (2019) Megan D Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children
- (2019) Itay Tokatly Latzer et al. Pediatric Critical Care Medicine
- Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia infections
- (2019) Cara Nys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
- (2019) Eun Jin Kim et al. BMC INFECTIOUS DISEASES
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model
- (2019) Iris H. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis
- (2019) Adrian Schmid et al. Scientific Reports
- Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years
- (2018) Consuelo Velázquez-Acosta et al. SUPPORTIVE CARE IN CANCER
- Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections
- (2018) Lucas Watson et al. Journal of Global Antimicrobial Resistance
- Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
- (2018) J.-H. Ko et al. CLINICAL MICROBIOLOGY AND INFECTION
- Heterogeneous Colistin-Resistance Phenotypes Coexisting in Stenotrophomonas maltophilia Isolates Influence Colistin Susceptibility Testing
- (2018) Sònia Martínez-Servat et al. Frontiers in Microbiology
- Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series
- (2017) Hirotaka Ebara et al. INTERNAL MEDICINE
- Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy
- (2017) Anthony A. Adegoke et al. Frontiers in Microbiology
- Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape
- (2016) R. M. Humphries et al. CLINICAL INFECTIOUS DISEASES
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study
- (2016) Ching-Hsun Wang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Plea for routinely presenting prediction intervals in meta-analysis
- (2016) Joanna IntHout et al. BMJ Open
- Meta-analyses: what is heterogeneity?
- (2015) P. Sedgwick BMJ-British Medical Journal
- Meta-analyses: what is heterogeneity?
- (2015) P. Sedgwick BMJ-British Medical Journal
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- Clinical Factors Associated with Acquisition of Resistance to Levofloxacin inStenotrophomonas maltophilia
- (2014) Ji Hyeon Baek et al. YONSEI MEDICAL JOURNAL
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections
- (2012) Yasemin Tezer Tekçe et al. JOURNAL OF CHEMOTHERAPY
- Reconstructing 2 x 2 contingency tables from odds ratios using the Di Pietrantonj method: difficulties, constraints and impact in meta-analysis results
- (2012) Areti Angeliki Veroniki et al. Research Synthesis Methods
- Contribution of Resistance-Nodulation-Division Efflux Pump OperonsmeU1-V-W-U2-Xto Multidrug Resistance of Stenotrophomonas maltophilia
- (2011) Chao-Hsien Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
- (2011) Keith A. Rodvold et al. CLINICAL PHARMACOKINETICS
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical and Microbiologic Outcomes in Trauma Patients Treated forStenotrophomonas maltophiliaVentilator-Associated Pneumonia
- (2011) Quinn A Czosnowski et al. PHARMACOTHERAPY
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia
- (2008) J. I. Garcia Paez et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation